Preclinical validation of a novel compound targeting p70S6 kinase in breast cancer

SOL784Paper
Written By James Cotton
James Cotton
Previous

Preclinical validation of a novel compound targeting p70S6 Kinase in breast cancer
Next

Targeting Translation Control with p70 S6 Kinase 1 Inhibitors to Reverse Phenotypes in Fragile X Syndrome Mice